DenovAI Biotech Ltd
General Data
Reg Number
516751294
Sector
Digital Health
Established
2023
No. of Employees
11
Stage
R&D
Additional Funding
1
Description
At DenovAI, we are pioneering a groundbreaking generative AI-Physics platform for the de novo design of novel proteins. The company’s vision is to be the foundation on which many life science verticals will be built in the future.
Technology
DenovAI is a developer of artificial intelligence-enabled computational biophysics platform, designed to discover potential antibodies directed toward specific epitopes. The company's platform designs antibodies from scratch and then suggests, which candidates will likely make effective drugs, enabling medical professionals to transform human health into new and upgraded standards.
Targeted Customers
Medical professionals.
Management personnel
Kashif Sadiq - CEO & Founder
Winning details
Route name
Winning year
Technological Innovation Labs
Technological Innovation Labs
2025
Increasing participation of Israeli industrial corporations in the European Horizon program
Increasing participation of Israeli industrial corporations in the European Horizon program
2025